| Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country C Dye, S Scheele, V Pathania, MC Raviglione Jama 282 (7), 677-686, 1999 | 4882 | 1999 |
| The growing burden of tuberculosis: global trends and interactions with the HIV epidemic EL Corbett, CJ Watt, N Walker, D Maher, BG Williams, MC Raviglione, ... Archives of internal medicine 163 (9), 1009-1021, 2003 | 4174 | 2003 |
| Global strategy to accelerate the elimination of cervical cancer as a public health problem World Health Organization World Health Organization, 2020 | 3318* | 2020 |
| Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic MC Raviglione, DE Snider, A Kochi Jama 273 (3), 220-226, 1995 | 2671 | 1995 |
| Drivers of tuberculosis epidemics: the role of risk factors and social determinants K Lönnroth, E Jaramillo, BG Williams, C Dye, M Raviglione Social science & medicine 68 (12), 2240-2246, 2009 | 1392 | 2009 |
| Global tuberculosis incidence and mortality during 1990-2000. PJ Dolin, MC Raviglione, A Kochi Bulletin of the World Health Organization 72 (2), 213, 1994 | 1359 | 1994 |
| Global surveillance for antituberculosis-drug resistance, 1994–1997 A Pablos-Méndez, MC Raviglione, A Laszlo, N Binkin, HL Rieder, ... New England Journal of Medicine 338 (23), 1641-1649, 1998 | 1342 | 1998 |
| WHO's new end TB strategy M Uplekar, D Weil, K Lonnroth, E Jaramillo, C Lienhardt, HM Dias, ... The Lancet 385 (9979), 1799-1801, 2015 | 1304 | 2015 |
| Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. O Cosivi, JM Grange, CJ Daborn, MC Raviglione, T Fujikura, D Cousins, ... Emerging infectious diseases 4 (1), 59, 1998 | 1276 | 1998 |
| Tuberculosis control and elimination 2010–50: cure, care, and social development K Lönnroth, KG Castro, JM Chakaya, LS Chauhan, K Floyd, P Glaziou, ... The lancet 375 (9728), 1814-1829, 2010 | 1162 | 2010 |
| Global trends in resistance to antituberculosis drugs MA Espinal, A Laszlo, L Simonsen, F Boulahbal, SJ Kim, A Reniero, ... New England Journal of Medicine 344 (17), 1294-1303, 2001 | 1106 | 2001 |
| Latent Mycobacterium tuberculosis Infection H Getahun, A Matteelli, RE Chaisson, M Raviglione New England Journal of Medicine 372 (22), 2127-2135, 2015 | 983 | 2015 |
| Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries MA Espinal, SJ Kim, PG Suarez, KM Kam, AG Khomenko, GB Migliori, ... Jama 283 (19), 2537-2545, 2000 | 916 | 2000 |
| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 870 | 2015 |
| WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update D Falzon, E Jaramillo, HJ Schünemann, M Arentz, M Bauer, J Bayona, ... European Respiratory Journal 38 (3), 516-528, 2011 | 797 | 2011 |
| Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally C Dye, CJ Watt, DM Bleed, SM Hosseini, MC Raviglione Jama 293 (22), 2767-2775, 2005 | 774 | 2005 |
| Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries H Getahun, A Matteelli, I Abubakar, MA Aziz, A Baddeley, D Barreira, ... European Respiratory Journal 46 (6), 1563-1576, 2015 | 717 | 2015 |
| Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project DL Cohn, F Bustreo, MC Raviglione Clinical infectious diseases 24 (Supplement_1), S121-S130, 1997 | 665 | 1997 |
| Financial burden for tuberculosis patients in low-and middle-income countries: a systematic review T Tanimura, E Jaramillo, D Weil, M Raviglione, K Lönnroth European Respiratory Journal 43 (6), 1763-1775, 2014 | 642 | 2014 |
| WHO's new Stop TB Strategy MC Raviglione, MW Uplekar The Lancet 367 (9514), 952-955, 2006 | 624 | 2006 |
